000 01617 a2200421 4500
005 20250513090549.0
264 0 _c19960621
008 199606s 0 0 eng d
022 _a0165-4608
024 7 _a10.1016/0165-4608(95)00304-5
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFleischman, E W
245 0 0 _aTranslocation (2;3)(p13;q26) in two cases of myeloid malignancies. Acute myeloblastic leukemia (M2) and blastic phase of chronic myeloid leukemia.
_h[electronic resource]
260 _bCancer genetics and cytogenetics
_cApr 1996
300 _a182-4 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAdolescent
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aCytarabine
_xadministration & dosage
650 0 4 _aDoxorubicin
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aKaryotyping
650 0 4 _aLeukemia, Myelogenous, Chronic, BCR-ABL Positive
_xdrug therapy
650 0 4 _aLeukemia, Myeloid, Acute
_xdrug therapy
650 0 4 _aMale
650 0 4 _aPrednisolone
_xadministration & dosage
650 0 4 _aPrednisone
_xadministration & dosage
650 0 4 _aTranslocation, Genetic
650 0 4 _aVincristine
_xadministration & dosage
700 1 _aVolkova, M A
700 1 _aFrenkel, M A
700 1 _aKonstantinova, L N
700 1 _aKulagina, O E
700 1 _aBaranov, A E
700 1 _aGordeeva, A A
773 0 _tCancer genetics and cytogenetics
_gvol. 87
_gno. 2
_gp. 182-4
856 4 0 _uhttps://doi.org/10.1016/0165-4608(95)00304-5
_zAvailable from publisher's website
999 _c8624315
_d8624315